The first successful gene therapy, which is considered a milestone achievement, employs ex vivo gene therapy to treat severe combined immunodeficiency (SCID) caused by adenosine deaminase (ADA) deficiency. This evidence concerns the gene ADA and severe combined immunodeficiency.